Abstract

1. Assemble and report on a periodic basis, cancer incidence rates in SEER areas, and cancer mortality rates in the United States; 2. Monitor annual cancer incidence trends to identify unusual changes in specific forms of cancer occurring in population subgroups defined by geographic, demographic, and social characteristics; 3. Provide continuing information on changes over time in the extent of disease at diagnosis, therapy, and associated changes in cancer patient survival; 4. Implement specific studies designed to identify factors amenable to cancer control interventions including environmental, occupational, socioeconomic, dietary, and health-related exposures; and screening practices, early detection, treatment and other determinants of the extent and quality of patient survival.

  Funding Agency

Agency
National Institute of Health (NIH)
Institute
Division of Cancer Prevention And Control (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CN067009-001
Application #
3676547
Study Section
Project Start
1996-08-01
Project End
2003-07-31
Budget Start
1996-09-30
Budget End
1997-03-31
Support Year
Fiscal Year
1996
Total Cost
Indirect Cost

  Institution

Name
Fred Hutchinson Cancer Research Center
Department
Type
DUNS #
075524595
City
Seattle
State
WA
Country
United States
Zip Code
98109

  Publications

Madeleine, Margaret M; Anttila, Tarja; Schwartz, Stephen M et al. (2007) Risk of cervical cancer associated with Chlamydia trachomatis antibodies by histology, HPV type and HPV cofactors. Int J Cancer 120:650-5
Andersen, M Robyn; Schroeder, Tom; Gaul, Marcia et al. (2005) Using a population-based cancer registry for recruitment of newly diagnosed patients with ovarian cancer. Am J Clin Oncol 28:17-20
Doherty, Jennifer A; Weiss, Noel S; Freeman, Robert J et al. (2005) Genetic factors in catechol estrogen metabolism in relation to the risk of endometrial cancer. Cancer Epidemiol Biomarkers Prev 14:357-66
Friedrichsen, Danielle M; Malone, Kathleen E; Doody, David R et al. (2004) Frequency of CHEK2 mutations in a population based, case-control study of breast cancer in young women. Breast Cancer Res 6:R629-35
Suter, Nicola M; Malone, Kathleen E; Daling, Janet R et al. (2003) Androgen receptor (CAG)n and (GGC)n polymorphisms and breast cancer risk in a population-based case-control study of young women. Cancer Epidemiol Biomarkers Prev 12:127-35
Littman, Alyson J; Rossing, Mary Anne; Madeleine, Margaret M et al. (2003) Association between late age at infectious mononucleosis, Epstein-Barr virus antibodies, and ovarian cancer risk. Scand J Infect Dis 35:728-35
Potosky, Arnold L; Reeve, Bryce B; Clegg, Limin X et al. (2002) Quality of life following localized prostate cancer treated initially with androgen deprivation therapy or no therapy. J Natl Cancer Inst 94:430-7
Custer, Brian S; Koepsell, Thomas D; Mueller, Beth A (2002) The association between breast carcinoma and meningioma in women. Cancer 94:1626-35
Newcomer, L M; King, I B; Wicklund, K G et al. (2001) The association of fatty acids with prostate cancer risk. Prostate 47:262-8
Potosky, A L; Knopf, K; Clegg, L X et al. (2001) Quality-of-life outcomes after primary androgen deprivation therapy: results from the Prostate Cancer Outcomes Study. J Clin Oncol 19:3750-7

Showing the most recent 10 out of 14 publications